13.94 USD
▼-1.04-6.94%
盘后 13.67 -1.94%
2026-10-16
市值
$443.08M
市盈率
—
EPS
-31.83
股息率
—
52 周区间
13.31 – 27.99
成交量
293.11K
Beta
—
目标价
35.40
52W 低 13.3152W 高 27.99
价格走势
公司简介
BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndrome (HR-MDS). BlossomHill Therapeutics, Inc. was incor...